ALJ Health partners with EQRx to develop affordable cancer treatments for 1.5 billion people
Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and EQRx, a pharmaceutical company committed to developing and delivering new medicines to patients at significantly lower prices, have entered into a strategic collaboration for the commercialization of two affordable novel lung cancer therapeutics for millions of people across